Caricamento...
Reslizumab in the management of poorly controlled asthma: the data so far
Interleukin-5, an important cytokine in the pathophysiology of asthma, participates in terminal maturation and increases chemotaxis, endothelial adhesion, and activation of eosinophils. Blockade of interleukin-5 activity with monoclonal antibodies have been successful in decreasing eosinophil counts...
Salvato in:
| Pubblicato in: | J Asthma Allergy |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5012840/ https://ncbi.nlm.nih.gov/pubmed/27621657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S94164 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|